314
Participants
Start Date
September 19, 2011
Primary Completion Date
May 16, 2013
Study Completion Date
May 16, 2013
Extended-release Guanfacine Hydrochloride
The test product will be provided as 1, 2, 3, and 4mg tablets. Subjects will be administered a once-daily dose between 1-7mg/day depending on weight.
Placebo
Matching placebo will be provided as 1,2,3, and 4mg tablets. Subjects will be administered a once-daily dose of placebo between 1-7mg/day depending on weight.
Richmond Behavioral Associates, Staten Island
Finger Lakes Clinical Research, Rochester
CRI Worldwide, Philadelphia
University Services Sleep Diagnostic and Treatment Centers, West Chester
Neuroscience, Inc., Herndon
Alliance Research Group, Richmond
Triangle Neuropsychiatry, Durham
Rainbow Research, Barnwell
Northwest Behavioral Research Center, Roswell
Institute for Behavioral Medicine, Smyrna
Clinical Neuroscience Solutions, Inc., Jacksonville
George M. Joseph, MD, PA, Jacksonville Beach
Sarkis Clinical Trials, Gainesville
Morteza Nadjafi, MD, FAPA, Orlando
Clinical Neuroscience Solutions, Inc., Orlando
Amedica Research Institute, Inc., Hialeah
Miami Research Associates, South Miami
Janus Center for Psychiatric Research, West Palm Beach
Florida Clinical Research Center, LLC, Bradenton
Harmonex Neuroscience Research, Dothan
Clinical Neuroscience Solutions, Inc., Memphis
Research Strategies of Memphis, LLC, Memphis
The Jackson Clinic, Jackson
Four Rivers Clinical Research, Inc., Paducah
The Ohio State University, Columbus
NorthCoast Clinical Trials, Beachwood
Goldpoint Clinical Research, LLC, Indianapolis
Clinco, Inc., Terre Haute
Rochester Center for Behavioral Medicine, Rochester Hills
Clinical Neurophysiology Services, PC, Sterling Heights
Capstone Clinical Research, Libertyville
AMR-Baber Research Inc., Naperville
St Charles Psychiatric Associates - Midwest Research Group, Saint Charles
Comprehensive Psychiatric Associates, Gladstone
Psychiatric Associates, Overland Park
Clinical Study Centers, LLC, Little Rock
IPS Research Company, Oklahoma City
Tulsa Clinical Research, LLC, Tulsa
InSite Clinical Research, DeSoto
R/D Clinical Research, Inc., Lake Jackson
FutureSearch Trials, Austin
Westex Clinical Investigations, Lubbock
IMMUNO International Research Centers, Centennial
Albuquerque Neuroscience Inc., Albuquerque
Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas
Peninsula Research Associates, Rolling Hills Estates
Encompass Clinical Research, Spring Valley
Psychiatric Centers at San Diego (PCSD-Feighner Research Institute), San Diego
Elite Clinical Trials, Inc., Wildomar
OCCI, Inc., Portland
Oregon Center for Clinical Investigations, Inc., Salem
Northwest Clinical Research Center, Bellevue
East Side Therapeutic Resource, Kirkland
Coastal Connecticut Research LLC, New London
Lead Sponsor
Shire
INDUSTRY